Literature DB >> 32819575

MicroRNA-27a-3p directly targets FosB to regulate cell proliferation, apoptosis, and inflammation responses in immunoglobulin a nephropathy.

Yu Liao1, Ziyan Wang2, Lixin Wang3, Yanzhao Lin3, Ziyi Ye3, Xufang Zeng3, Fangning Wei4.   

Abstract

Immunoglobulin A nephropathy (IgAN) constitutes the most common primary glomerulonephritis worldwide; however, the exact pathogenesis of IgAN is unknown. Previous genome-wide analysis of microRNA (miRNA) expression in the kidney has confirmed that miRNAs are closely related to the pathological changes of IgAN. Accordingly, in this study we found that miR-27a-3p is upregulated in IgAN kidney tissues in addition to human podocytes and tubule epithelial HK2 but not mesangial cells. Methylthiazolyldiphenyl-tetrazolium bromide (MTT), flow cytometry, real-time polymerase chain reaction, western blot, and enzyme-linked immunosorbent assays were used to verify the regulatory effects of miR-27a-3p and its inhibition on cell proliferation, apoptosis, and release of inflammatory factors in podocytes and HK2 cells. The target genes of miR-27a-3p were predicted using bioinformatics software; the identity of FosB as a target gene of miR-27a-3p was confirmed by luciferase report assay and western blot. Overall, our findings demonstrated that miR-27a-3p regulates cell apoptosis, cell proliferation, and the release of inflammatory cytokines of human podocytes and HK2 cells by directly targeting FosB. Our results therefore suggested that miR-27a-3p might be associated with the pathophysiology of IgAN and may represent a potential target for further studies related to IgAN mechanism or therapeutics.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FosB; IgAN; Inflammatory cytokine; Kidney function; MiRNA-27a-3p

Year:  2020        PMID: 32819575     DOI: 10.1016/j.bbrc.2020.06.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Identification of Metabolic Syndrome-Related miRNA-mRNA Regulatory Networks and Key Genes Based on Bioinformatics Analysis.

Authors:  Lingyan Qiu; Pei Sheng; Xu Wang
Journal:  Biochem Genet       Date:  2022-07-25       Impact factor: 2.220

2.  Computational Analysis Reveals the Characteristics of Immune Cells in Glomerular and Tubulointerstitial Compartments in IgA Nephropathy Patients.

Authors:  Bin Li; Suchun Li; Yuting Fan; Hui Diao; Siyang Ye; Huajing Peng; Wei Chen
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

3.  Biliverdin Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating the miR-27a-3p/Rgs1 Axis.

Authors:  Junjie Li; Lijia Peng; Wenya Bai; Peihua Peng; Wendong Chen; Wei Yang; Jianlin Shao
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-22       Impact factor: 2.570

4.  Transmembrane signaling molecules play a key role in the pathogenesis of IgA nephropathy: a weighted gene co-expression network analysis study.

Authors:  Alieh Gholaminejad; Amir Roointan; Yousof Gheisari
Journal:  BMC Immunol       Date:  2021-12-03       Impact factor: 3.615

5.  Identifying DUSP-1 and FOSB as hub genes in immunoglobulin A nephropathy by WGCNA and DEG screening and validation.

Authors:  Wu Jianping; Xiaona Wei; Jiajia Li; Rui Zhang; Qianqian Han; Qiongqiong Yang
Journal:  PeerJ       Date:  2022-07-25       Impact factor: 3.061

6.  N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.

Authors:  Li Zhou; Xiao Han; Wei Li; Ning Wang; Lan Yao; Yunhe Zhao; Liqun Zhang
Journal:  Reprod Sci       Date:  2021-07-12       Impact factor: 3.060

7.  Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.

Authors:  Md Parvez Mosharaf; Md Selim Reza; Md Kaderi Kibria; Fee Faysal Ahmed; Md Hadiul Kabir; Sohel Hasan; Md Nurul Haque Mollah
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.